ExodusPoint Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

ExodusPoint Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,929	Closed	-$400K	–	1527
2025 Q4	$400K	Buy	+14,929	New	+$385K	﹤0.01%	1232
2025 Q3	–	Sell	-32,444	Closed	-$745K	–	1502
2025 Q2	$745K	Sell	32,444 -310,848	-91%	-$7.71M	0.01%	1048
2025 Q1	$9.95M	Buy	+343,292	New	+$11M	0.1%	209
2024 Q4	–	Sell	-6,961	Closed	-$338K	–	1483
2024 Q3	$338K	Sell	6,961 -44,354	-86%	-$1.95M	﹤0.01%	1324
2024 Q2	$2.05M	Sell	51,315 -3,216	-6%	-$133K	0.01%	766
2024 Q1	$2.39M	Buy	54,531 +42,235	+343%	+$2.18M	0.02%	634
2023 Q4	$761K	Buy	12,296 +7,410	+152%	+$389K	0.01%	912
2023 Q3	$225K	Sell	4,886 -14,495	-75%	-$791K	﹤0.01%	1491
2023 Q2	$1.11M	Buy	+19,381	New	+$859K	0.01%	1062
2023 Q1	–	Sell	-14,515	Closed	-$407K	–	1722
2022 Q4	$407K	Buy	+14,515	New	+$421K	0.01%	1254
2020 Q3	–	Sell	-12,732	Closed	-$286K	–	1714
2020 Q2	$286K	Buy	+12,732	New	+$233K	0.01%	1340

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

ExodusPoint Capital Management's AMPH Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 14,929 shares — an estimated $400K sold.

ExodusPoint Capital Management first reported a position in AMPH in Q2 2020 and held it in 11 quarters. The position peaked at $9.95M in Q1 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

ExodusPoint Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 14,929 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $400K.
ExodusPoint Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2020 and held it in 11 quarters.
ExodusPoint Capital Management's Amphastar Pharmaceuticals position peaked at $9.95M in Q1 2025.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.